Molina Healthcare Inc header image

Molina Healthcare Inc

MOH

Equity

ISIN US60855R1005 / Valor 1538184

New York Stock Exchange, Inc (2025-03-07)
USD 327.33+1.08%

Molina Healthcare Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Molina Healthcare Inc is a prominent health care provider that specializes in offering high-quality, affordable health care services primarily to individuals and families who are beneficiaries of government-sponsored health care programs. Founded in 1980 with a single clinic in Long Beach, the company has significantly expanded its operations over the past four decades. It now operates 19 health plans across the United States, catering to the needs of over 5.1 million members. Molina Healthcare is dedicated to addressing the comprehensive health needs of its members, including their physical, social, and emotional well-being, through a community-based approach tailored to each individual's requirements. The company's growth is also marked by its initiative, the MolinaCares Accord, launched in 2020, which aims to enhance access to health care for its members by making substantial investments in the communities it serves.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (17.12.2024):

Premium Revenue

Molina Healthcare Inc. reported premium revenue of approximately $9.7 billion for the third quarter of 2024, marking an 18% increase compared to the same period in 2023. This growth was driven by new contract wins, acquisitions, and expansion within existing markets, although it was partially offset by the impact of Medicaid redeterminations.

Net Income

For the third quarter of 2024, Molina Healthcare Inc. achieved a GAAP net income of $5.65 per diluted share, representing a 34% increase year over year. The adjusted net income was $6.01 per diluted share, reflecting a 19% increase from the previous year.

Medical Care Ratio (MCR)

The consolidated Medical Care Ratio (MCR) for Molina Healthcare Inc. in the third quarter of 2024 was 89.2%. This ratio indicates the company's ongoing efforts to manage medical costs effectively. The Medicaid MCR was 90.5%, influenced by a retroactive premium rate reduction and new Medicaid plans, while the Medicare MCR was 89.6%, reflecting higher-than-expected utilization.

General and Administrative Expense Ratio

Molina Healthcare Inc. reported a General and Administrative (G&A) expense ratio of 6.5% for the third quarter of 2024, with an adjusted G&A ratio of 6.4%. These figures highlight the company's disciplined cost management, benefiting from one-time credits related to vendor contracts and operational leverage.

2024 Guidance

Molina Healthcare Inc. reaffirmed its full-year 2024 guidance, projecting premium revenue of approximately $38 billion, a 17% increase from 2023. The company also expects adjusted earnings per diluted share to be at least $23.50, representing a 13% growth over the previous year, driven by strong performance in the Marketplace and higher net investment income.

Summarized from source with an LLMView Source

Key figures

-16.5%1Y
4.97%3Y
137%5Y

Performance

40.3%1Y
32.6%3Y
37.0%5Y

Volatility

Market cap

16553 M

Market cap (USD)

Daily traded volume (Shares)

1,060,987

Daily traded volume (Shares)

1 day high/low

290.43 / 287.24

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.42%CHF 307.00
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.46%CHF 100.92
Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%CHF 117.80
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%CHF 274.60
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%CHF 187.90
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%CHF 81.90
Siegfried Holding Ltd
Siegfried Holding Ltd Siegfried Holding Ltd Valor: 1428449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%CHF 923.00
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.03%CHF 336.50
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.06%CHF 54.30
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.28%CHF 19.56